Veravas, Inc.

Veravas, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Veravas is a leading innovator in clinical diagnostics focused on the early-stage detection of Alzheimer’s disease and other neurological conditions. The company’s proprietary VeraBIND™ technology transforms challenging sample types into measurable biomarkers, enabling earlier disease detection and the development of novel diagnostic tests. Its VeraBIND Tau assay is a first-in-class blood-based test that measures the pathological activity of hyperphosphorylated tau in blood samples of cognitively normal individuals or individuals experiencing cognitive impairment which may be used to aid in the diagnosis of Alzheimer's disease.
Looking for a particular Veravas, Inc. employee's phone or email?

Veravas, Inc. Questions

News

Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology - PR Newswire

Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology PR Newswire

Can new Alzheimer’s tests help clear the way for the next generation of therapies? - Pharma Voice

Can new Alzheimer’s tests help clear the way for the next generation of therapies? Pharma Voice

Evaluating the VeraBIND Tau Assay for Earlier Detection of Alzheimer Disease: John Forrest - NeurologyLive

Evaluating the VeraBIND Tau Assay for Earlier Detection of Alzheimer Disease: John Forrest NeurologyLive

Veravas Partners with Phanes Biotech to Co-develop a Next-generation Blood-based Tau Pathology Test to Improve Alzheimer's Disease Detection - BioSpace

Veravas Partners with Phanes Biotech to Co-develop a Next-generation Blood-based Tau Pathology Test to Improve Alzheimer's Disease Detection BioSpace

First Blood-Based Tau Pathology Test Advances Alzheimer’s Diagnostics - Inside Precision Medicine

First Blood-Based Tau Pathology Test Advances Alzheimer’s Diagnostics Inside Precision Medicine

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer's Disease Presented at the 2025 Alzheimer's Association International Conference - PR Newswire

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer's Disease Presented at the 2025 Alzheimer's Association International Conference PR Newswire

Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood - BioSpace

Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood BioSpace

Top Veravas, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant